FULCRUM THERAPEUTICS, INC. (FULC)

Every figure this model derived for FULC, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2025-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 365,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 48,466,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 322,851,000 AssetsCurrent 2026-06-30
current liabilities 10,298,000 LiabilitiesCurrent 2026-06-30
equity 310,697,000 StockholdersEquity 2026-06-30
ocf -65,777,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 0 RevenueFromContractWithCustomerIncludingAssessedTax 2025-12-31
sbc 13,557,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up FULC on one particular measure came for.

RatioValue
current ratio31.35
current ratio reported31.35
deferred revenue growth-100.0
dilution pct2.21
growth cv2.1
revenue growth-100.0
revenue growth per share-100.0
roic-28.94

What to be careful about

What this model itself distrusts about FULC's figures. Written by the derivation as it ran, not added afterwards.